• Neurocrine Biosciences Announces Repurchase of Convertible Notes

    11 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 19, 2020 /PRNewswire/ - Neurocrine Biosciences, Inc. today announced that the Company has entered into separate, privately negotiated transactions with certain holders of its existing 2.25% Convert......
    Read more ...

     

  • Neurocrine Biosciences to Present at Upcoming Healthcare Conferences

    11 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 19, 2020 /PRNewswire/ - Neurocrine Biosciences, Inc. today announced that Neurocrine Biosciences management will present at the following investor conferences:
    Matt Abernethy, Chief Financial Officer, and Eiry......
    Read more ...